foxo4-dri senolytic 2024

foxo4-dri senolytic 2024 foxo4 dri study improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells FOXO4-DRI: The Senolytic Peptide That – FOXO4-DRI: Human Trial Status, Cancer

Name: foxo4-dri senolytic 2024 foxo4 dri study improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells FOXO4-DRI: The Senolytic Peptide That – FOXO4-DRI: Human Trial Status, Cancer
Brand: usmivani.cz
SKU: 3470015310
Price: 28.86 USD
Availability: InStock
Rating: 4.0594 (17 reviews)

FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data PDF) Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI 10mg vial Description RCpeptides

SKU: 3470015310 · From usmivani.cz

4.1

USD28.86 USD76.86

Pay in 4 interest-free payments of $7.21 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

The compound has remained a recognised subject of scientific investigation for decades due to its defined molecular structure, extensive research history and suitability for experimental peptide research models